DYRK1A and prostate carcinoma: Although effective in other cases, notably against breast and prostate cancers, this avenue has not yet been exploited in the case of DYRK1A regulation Broad therapeutic implications related to DYRK1A’s roles as a tumor suppressor and mediator of radiosensitivity were highlighted in the past years [137,143].